The scientific literature of recent years contains a lot of data about using multipotent stromal cells (MSCs) for urinary incontinence correction. Despite this, the ideal treatment method for urinary incontinence has not yet been created. The cell therapy results in patients and experimental animals with incontinence have shown promising results, but the procedures require further optimization, and more research is needed to focus on the clinical phase. The MSC use appears to be a feasible, safe, and effective method of treatment for patients with urinary incontinence. However, the best mode for application of cell technology is still under study. Most clinical investigations have been performed on only a few patients and during rather short follow-up periods, which, together with an incomplete knowledge of the mechanisms of MSC action, does not make it possible for their widespread implementation. The technical details regarding the MSC application remain to be identified in more rigorous preclinical and clinical trials.
Implants made of biodegradable polymers are replaced by regenerating tissues through inflammation. The changes occurring in tissues and the organism are of practical interest for studying the biocompatibility of the material and searching for systemic markers in the blood that reflect inflammation in peri-implantation tissues. The highly sensitive C-reactive protein (hs-CRP) measurements in blood and morphometric studies of tissue surrounding the implant were carried out in the experiment within three months of implantation of a biopolymer consisting of polycaprolactone (PCL) and polytrimethylene carbonate (PTMC). During the first month, tissue inflammation decreased, and the blood level of hs-CRP did not increase. The polymer biotransformation began in the tissues after a month of implantation and was accompanied by inflammation moving deeper into the matrix. Proliferation of inflammatory cells in tissues was reflected in an increase in the hs-CRP level three months after polymer installation. The result achieved confirmed the polymer’s bioinertness. The level of hs-CRP in the blood of the animals correlated with the level of inflammation in peri-implantation tissues, reflecting the activity of inflammation in the process of polymer biotransformation. This inflammation protein can be recommended for assessing tissue processes following implantation of biopolymers and their biocompatibility.
In recent decades, the use of polypropylene meshes has been the gold standard in the surgical treatment of muscular corset failure. However, the reasons behind the low percentage of complications and recurrences remain controversial. Tissue hyperreactivity and the immune response to polypropylene may be contributing factors. Measurements of the level of hs-CRP (highly sensitive C-reactive protein) in the blood and morphometric studies of tissues around the implant were carried out for three months after the installation of polypropylene implants in 53 laboratory rats. The research results confirmed the good biocompatibility of polypropylene and the formation of full-fledged connective tissue around polypropylene three months after the installation of the material. The level of hs-CRP in the blood increased slightly, without significant differences, but in some animals, there was a sharp increase in this indicator at 3 months. Such results may indicate the development of hyperreactivity to the implantation of a synthetic material and, with other accompanying factors, lead to the development of complications both at the local tissue and general immune levels.
The replacement of polypropylene with biodegradable polymers for surgical reinforcement of musculo-fascial structures is of considerable clinical interest. A study in 98 laboratory rats with implanted polypropylene or biodegradable biopolymer demonstrated the formation of dense irregular connective tissue at the surgical site instead of biopolymer and dense regular connective tissue around the polypropylene. The fibroblastic response to the biopolymer lagged behind that to polypropylene by approximately nine months, reflecting gradual polymer degradation, but did not differ between groups at 12 months, when the biopolymer had completely biotransformed. In both groups, newly formed connective tissue contained numerous elastic fibers and relatively fewer type I (COLI) and type III (COLIII) collagen fibers compared with intact preoperative tissue. In peri-implant tissue from both groups, COLIII fibers significantly predominated over COLI, with a higher volume fraction of COLIII around the polypropylene than around the biopolymer, whereas COLI was significantly more abundant in intact tissues. These findings are consistent with the good extensibility and low tear resistance of newly formed connective tissue. In the polypropylene group, polymer filaments reinforced this tissue mechanically. Further analysis of explanted tissues is required to determine the functional properties of connective tissue remodeled at the site of a degraded biopolymer implant.
The use of biodegradable polymers for the surgical reinforcement of musculofascial structures is of considerable practical interest. Research into the applicability of biopolymers should be conducted in comparison with polypropylene, a material used in surgery. Using highly sensitive C-reactive protein (hs-CRP) in blood and interleukin-6 (IL-6) and CD34 (an endothelial marker with angiogenic properties) in tissues, we analyzed the systemic and local tissue responses to polypropylene and biodegradable polymer implantation in 42 laboratory rats over a three-month period. The study confirmed good biocompatibility of both polymers. However, the systemic and tissue responses to the biopolymer, as measured by the studied markers, were significantly less pronounced compared to polypropylene. Persistently elevated levels of hs-CRP and CD34-positive cells in the biopolymer group at three months post-implantation were attributed to ongoing biotransformation processes. The mild inflammatory response following biopolymer implantation confirms not only its bioinert properties but also its potential for practical surgical applications. Elevated levels of hs-CRP and CD34-, as well as IL-6-positive cells in the polypropylene group, warrant further investigation of long-term responses to polypropylene as potential contributors to post-implantation complications. The hs-CRP level correlated with tissue markers IL-6 and CD34, suggesting its utility as a criterion for assessing postoperative adaptation to implanted synthetic materials.